During the past decade, Futuro Clinical Trials, LLC conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 6 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 6 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Futuro Clinical Trials, LLC" #1 sponsor was "MiMedx Group, Inc." with 4 trials, followed by "Helixmith Co., Ltd." with 3 trials sponsored, "Ipsen" with 2 trials sponsored, "Organogenesis" with 2 trials sponsored and "Tissue Tech Inc." with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Futuro Clinical Trials, LLC" #1 collaborator was "Alira Health" with 1 trials as a collaborator, "Organogenesis" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator, "PrimeVigilance" with 1 trials as a collaborator and "Professional Education and Research Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Futuro Clinical Trials, LLC" are "Diabetic Foot Ulcers" (5 trials), "Diabetic Foot Infection" (3 trials), "Diabetic Foot Ulcer" (3 trials), "Foot Ulcer, Diabetic" (3 trials) and "Non-healing Diabetic Foot Ulcer" (2 trials). Many other conditions were trialed in "Futuro Clinical Trials, LLC" in a lesser frequency.

Most popular intervention types in "Futuro Clinical Trials, LLC" are "Other" (14 trials), "Biological" (13 trials), "Drug" (13 trials), "Device" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Standard of Care" (3 trials), "Engensis" (2 trials), "NuShield" (2 trials) and "Saline Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Futuro Clinical Trials, LLC" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Futuro Clinical Trials, LLC". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Futuro Clinical Trials, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Futuro Clinical Trials, LLC, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".